Vertex Pharmaceuticals | VRTX - 流动负债



金融业
股票价格
USD 498.50
资产
USD 27.42B
现金及等价物
USD 7.85B
销售成本
USD 489.2M
流动资产
USD 12.54B
流动负债
USD 3.94B
债务
USD 1.98B
EBIT
USD 1.27B
EBITDA
USD 1.33B
员工
6.1K
EPS每股收益
USD 4.73
股本和储备
USD 20.25B
销售毛利
USD 2.84B
债务利息支出
USD 3.3M
利息收入
USD 120.6M
贷款资金
USD 106.7M
市值
USD 127.89B
净收入
USD 1.1B
营业费用
USD 2.07B
营业利润
USD 1.27B
普通股股本
USD 253.3M
PE价格收益
28.05
税前利润
USD 1.39B
销售收入
USD 3.33B
销售和管理费用
USD 582.2M
股票
USD 1.77B
贸易债权人
USD 3.61B
应收帐款人
USD 2.13B


流动负债 更改 日
AbbVie USD 41.64B 458M 2026-06
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Incyte USD 1.31B 177.55M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 54.9B 2.82B 2026-06
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06